PYC Therapeutics (ASX:PYC) raised AU$9.3 million via the retail component of its entitlement offer, bringing the total funds raised to AU$100 million, according to a Tuesday filing with the Australian bourse.

On Feb. 17, the company said it is set to raise up to AU$146 million via a pro-rata accelerated non-renounceable entitlement offer on the basis of one new share for every four shares held.

The balance will be raised through an underwriting facility expected before April 7, the filing said.

Shares of the company fell almost 3% in recent Tuesday trade.